Patients Vanished from a Hospital Monitoring System During a Software Update and Alarm Settings Reset Themselves
GE HealthCare reported that a software update removed monitored patients from its Portrait system and reset alarms to factory defaults.
A Second Drug for the Disease That Turns Muscle into Bone Arrives at Seven Figure Pricing
The FDA approved Pasatru for adults with fibrodysplasia ossificans progressiva. Annual list pricing runs from $693,000 to $2.1 million.
Neonatal Breathing Circuits Recalled After Melting and Smoke Reports, with Two Item Numbering Systems Confusing Hospitals
The FDA issued an early alert after neonatal breathing circuits were found to be melting and emitting smoke. Medline wants all affected lots destroyed.
FDA Authorizes Eleven Stronger ZYN Pouches at Nine and Eleven Milligrams Under a Faster Review Pilot
FDA authorized 11 ZYN ULTRA nicotine pouches, ten at 9 mg and one at 11 mg, under a pilot program built to speed up its product reviews.
Patients with Wounds That Will Not Close Get a Rare Say in How Treatments Are Tested
FDA is hearing directly from patients with nonhealing chronic wounds today, and written comments stay open to anyone until October 26.
One Recalled Saline Ampule Set Off a Cascade of Kit Recalls Reaching Thousands of American Hospitals
FDA has posted a run of early alerts and recalls involving convenience kits, most tracing back to recalled drug ampules and syringes.
Alabama Sends 144 Million Dollars to Rural Clinics for Maternity Care, Mental Health and Emergency Transport
Alabama announced 138 grants totaling more than $144 million for rural healthcare, funding maternity care, telehealth, and school mental health.
Newborn Breathing Sets Are Being Pulled From Hospitals After Tubing Was Found Loosening From Nasal Cannulas
FDA issued an early alert on CooperSurgical INCA infant nasal CPAP sets after reports that the tubing can loosen and disconnect during use.
Experimental Tuberculosis Vaccine Fell Short of BCG in Nearly Seven Thousand African Newborns but Questions Remain
The phase 3 priMe trial found that VPM1002 was not noninferior to BCG in nearly 7,000 newborns, but the result is hard to interpret.
A Genome Test That Usually Takes Weeks Came Back in 3.4 Days and Redirected Care for 53 Children
Dubai's Little Falcon program sequenced 100 critically ill children in intensive care and changed treatment for more than half of them.